April 3 TPG Capital Management-backed IMS Health
Holdings Inc's initial public offering was priced at $20
per share, a market source said, valuing the healthcare
information company at about $6.64 billion.
With 65 million shares offered, the IPO raised about $1.30
billion at the offer price, which was slightly above the
mid-point of its expected price range of $18-$21 per share.
IMS is selling 52 million shares while the rest are being
offered by selling shareholders.
IMS provides prescription data to the pharmaceutical
industry, medical device makers, government agencies and other
companies in the healthcare sector. Founded in 1954, the company
has over 5,000 clients and operates in more than 100 countries,
according to its website.
IMS shares will start trading on Friday on the New York
Stock Exchange under the symbol "IMS."
JP Morgan, Goldman Sachs, Morgan Stanley and BofA Merrill
Lynch were among the underwriters for the IPO.
The company has a total of 331.892 million shares
(Reporting by Avik Das in Bangalore; Editing by Gopakumar